218 related articles for article (PubMed ID: 19726820)
1. Patient satisfaction is comparable to early discharge versus overnight observation after elective percutaneous coronary intervention.
Glaser R; Gertz Z; Matthai WH; Wilensky RL; Weiner M; Kolansky D; Hirshfeld J; Herrmann H
J Invasive Cardiol; 2009 Sep; 21(9):464-7. PubMed ID: 19726820
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS).
Heyde GS; Koch KT; de Winter RJ; Dijkgraaf MG; Klees MI; Dijksman LM; Piek JJ; Tijssen JG
Circulation; 2007 May; 115(17):2299-306. PubMed ID: 17420341
[TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial).
Kotowycz MA; Cosman TL; Tartaglia C; Afzal R; Syal RP; Natarajan MK
Am Heart J; 2010 Jan; 159(1):117.e1-6. PubMed ID: 20102876
[TBL] [Abstract][Full Text] [Related]
4. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
[TBL] [Abstract][Full Text] [Related]
5. Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.
Dirksen MT; Ronner E; Laarman GJ; van Heerebeek L; Slagboom T; van der Wieken LR; van der Wouw PA; Kiemeneij F
J Invasive Cardiol; 2005 Oct; 17(10):512-7. PubMed ID: 16204742
[TBL] [Abstract][Full Text] [Related]
6. Same-day discharge after coronary stenting: a feasibility study using a hemostatic femoral puncture closure device.
Yee KM; Lazzam C; Richards J; Ross J; Seidelin PH
J Interv Cardiol; 2004 Oct; 17(5):315-20. PubMed ID: 15491335
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
Coleman CI; McKay RG; Boden WE; Mather JF; White CM
Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
[TBL] [Abstract][Full Text] [Related]
8. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.
Rigattieri S; Biondi-Zoccai G; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Loschiavo P
J Interv Cardiol; 2008 Feb; 21(1):1-7. PubMed ID: 18086133
[TBL] [Abstract][Full Text] [Related]
9. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
10. Ambulatory discharge after transradial coronary intervention: Preliminary US single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study).
Jabara R; Gadesam R; Pendyala L; Chronos N; Crisco LV; King SB; Chen JP
Am Heart J; 2008 Dec; 156(6):1141-6. PubMed ID: 19033010
[TBL] [Abstract][Full Text] [Related]
11. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
[TBL] [Abstract][Full Text] [Related]
12. Stable and optimal anticoagulation is achieved with a single dose of intravenous enoxaparin in patients undergoing percutaneous coronary intervention.
Chen WH; Lau CP; Lau YK; Ng W; Lee PY; Yu CM; Ma E
J Invasive Cardiol; 2002 Aug; 14(8):439-42. PubMed ID: 12147872
[TBL] [Abstract][Full Text] [Related]
13. Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
Am J Cardiol; 2009 May; 103(10):1333-8. PubMed ID: 19427424
[TBL] [Abstract][Full Text] [Related]
14. Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.
Mehta SR; Steg PG; Granger CB; Bassand JP; Faxon DP; Weitz JI; Afzal R; Rush B; Peters RJ; Natarajan MK; Velianou JL; Goodhart DM; Labinaz M; Tanguay JF; Fox KA; Yusuf S;
Circulation; 2005 Mar; 111(11):1390-7. PubMed ID: 15781750
[TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
Berger JS; Roe MT; Gibson CM; Kilaru R; Green CL; Melton L; Blankenship JD; Metzger DC; Granger CB; Gretler DD; Grines CL; Huber K; Zeymer U; Buszman P; Harrington RA; Armstrong PW
Am Heart J; 2009 Dec; 158(6):998-1004.e1. PubMed ID: 19958867
[TBL] [Abstract][Full Text] [Related]
16. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
Morrison DA; Sacks J
Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
[TBL] [Abstract][Full Text] [Related]
17. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
18. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
19. Safety of same-day-discharge radial percutaneous coronary intervention: a retrospective study.
Ziakas AA; Klinke BP; Mildenberger CR; Fretz DE; Williams EM; Kinloch FR; Hilton j GJ
Am Heart J; 2003 Oct; 146(4):699-704. PubMed ID: 14564326
[TBL] [Abstract][Full Text] [Related]
20. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
